Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of AGN-199201 once daily compared to vehicle
for the treatment of persistent moderate to severe facial erythema associated with rosacea.